Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Mar 10;96(10):e6282. doi: 10.1097/MD.0000000000006282

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc.

This is an open access article distributed under the Creative Commons Attribution-No Derivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0

PMC Copyright notice

Resistance to antiretroviral drugs in HIV-1 from children in virological failure according to therapeutic regimens. (A) 1st-line regimens, (B) 2nd-line regimens. 3TC = lamivudine, ABC = abacavir, ATZ = atazanavir, AZT = zidovudine, d4T = stavudine, ddI = didanosine, DRV = darunavir, EFV = efavirenz, ETR = etravirine, FTC = emtricitabine, IDV = Indinavir, LPV = lopinavir, NFV = nelfinavir, NNRTI = non-nucleosidic reverse transcriptase inhibitor, NRTI = nucleosidic reverse transcriptase inhibitor, NVP = nevirapine, PI = protease inhibitor, r = ritonavir (which boosted other PIs), RPV = rilpivirine, SQV = saquinavir, TDF = tenofovir, TPV = tipravirine.